Table 1. Skeletal metastasis location of SMUP patients.
A. Metastasis (n = 286) | |||||
Location | p ※ | Cases | % | MST(months) | |
Solitaly | <0.01 | 93 | 32.5% | 39.0 | |
Multiple | - | 193 | 67.5% | 16.0 | |
B. Solitaly (n = 93) and Multiple (n = 193) | |||||
Location | site | cases | % | MST(months) | |
Solitaly | Spine | 44 | 15.4% | 11.0 | |
Extremity | 16 | 5.6% | 45.0 | ||
Pelvc bone | 16 | 5.6% | 43.0 | ||
Other | 17 | 5.9% | 37.5 | ||
Multiple | Single area | Spine Only | 51 | 17.8% | 9.0 |
Extremity Only | 4 | 1.4% | 39.0 | ||
Pelvis Only | 3 | 1.0% | 33.0 | ||
Double area | Spine+Extremity | 9 | 3.1% | 12.0 | |
Spine+Pelvis | 38 | 13.3% | 9.5 | ||
Extremity+Pelvis | 9 | 3.1% | 14.0 | ||
Triple area and other | Whole Body | 79 | 27.6% | 7.0 | |
C.PS (n = 286) | |||||
PS | p ※※ | Cases | % | MST(months) | |
0 | 0.065 | 12 | 4.2% | 45.0 | |
1 | 0.065 | 101 | 35.3% | 27.0 | |
2 | 0.065 | 67 | 23.4% | 20.0 | |
3 | - | 53 | 18.5% | 8.0 | |
4 | - | 53 | 18.5% | 14.0 |
MST: median survival time
※The relationship between solitry metastasis and the multiple metastasis were calculated by using the log-rank test
※※The relationship between PS and the metastatic status were calculated by using the t-test.